Literature DB >> 17235650

Ankylosing spondylitis presenting with macrophage activation syndrome.

Yin-Jun Lou1, Jie Jin, Wen-Yuan Mai.   

Abstract

Macrophage activation syndrome (MAS), which can also be considered as reactive hemophagocytic syndrome (HPS), is a rare and potentially fatal complication of rheumatic diseases. We describe a 42-year-old woman in whom MAS developed as a complication of ankylosing spondylitis (AS). She suffered from fever and low back pain before admission. Laboratory findings were pancytopenia, abnormal liver enzymes, increased ferritin levels, and positive for B27. Hyperplasia of hemophagocytic macrophages was confirmed in her bone marrow. High-dose steroids therapy resulted in clinical and laboratory improvements. In this patient, there was no possible causative factor of HPS (such as viral infection, lymphoma, and systemic lupus erythematosus) except the presence of AS. There have been no previously reported cases describing the relationship between AS and HPS. This case indicates that attention should be given to the possibility that certain patients with AS-associated cytopenia may display accompanying intramedullary hemophagocytic phenomena.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235650     DOI: 10.1007/s10067-007-0538-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Autoimmune-associated hemophagocytic syndrome.

Authors:  Shunichi Kumakura; Hiroto Ishikura; Masahiro Kondo; Yohko Murakawa; Junichi Masuda; Shotai Kobayashi
Journal:  Mod Rheumatol       Date:  2004       Impact factor: 3.023

Review 2.  Pathogenesis of ankylosing spondylitis and reactive arthritis.

Authors:  Tae-Hwan Kim; Wan-Sik Uhm; Robert D Inman
Journal:  Curr Opin Rheumatol       Date:  2005-07       Impact factor: 5.006

Review 3.  Spondyloarthritis: update on pathogenesis and management.

Authors:  John D Reveille; Frank C Arnett
Journal:  Am J Med       Date:  2005-06       Impact factor: 4.965

Review 4.  Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Silvia Magni-Manzoni; Angela Pistorio; Cristina Besana; Tiziana Foti; Nicolino Ruperto; Stefania Viola; Alberto Martini
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

5.  Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review.

Authors:  Robin Dhote; Jeanne Simon; Thomas Papo; Bruno Detournay; Laurent Sailler; Marie-Helene Andre; Jean-Louis Dupond; Claire Larroche; Anne-Marie Piette; Didier Mechenstock; Jean-Marc Ziza; Jean Arlaud; Anne-Sophie Labussiere; Agnes Desvaux; Vincent Baty; Philippe Blanche; Annette Schaeffer; Jean-Charles Piette; Loïc Guillevin; Alain Boissonnas; Boyan Christoforov
Journal:  Arthritis Rheum       Date:  2003-10-15

Review 6.  Pathogenesis of hemophagocytic syndrome (HPS).

Authors:  Claire Larroche; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2004-02       Impact factor: 9.754

Review 7.  Macrophage activation syndrome.

Authors:  Angelo Ravelli
Journal:  Curr Opin Rheumatol       Date:  2002-09       Impact factor: 5.006

  7 in total
  3 in total

Review 1.  Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab.

Authors:  Rahaf Baker; Jean W Liew; Paul D Simonson; Lori A Soma; Gordon Starkebaum
Journal:  Clin Rheumatol       Date:  2018-12-07       Impact factor: 2.980

2.  Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis.

Authors:  Chen Zhang; Chen Wang; Zhenyu Jia; Wenwen Tong; Delin Liu; Chongru He; Xuan Huang; Weidong Xu
Journal:  Oncotarget       Date:  2017-11-27

3.  Recurrent macrophage activation syndrome since toddler age in an adolescent boy with HLA B27 positive juvenile ankylosing spondylitis.

Authors:  Joon Hyeong Park; Yu Mi Seo; Seung Beom Han; Ki Hwan Kim; Jung Woo Rhim; Nack Gyun Chung; Myung Shin Kim; Jin Han Kang; Dae Chul Jeong
Journal:  Korean J Pediatr       Date:  2016-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.